Stimvia Expands Scientific Advisory Board and Commercial Leadership to Advance Global Market Expansion of Flagship URIS® Therapy
OSTRAVA, Czech Republic, May 13, 2026 /PRNewswire/ — Stimvia, a Czech medical technology company developing non-invasive neuromodulation therapies for overactive bladder (OAB), today announced the expansion of its Scientific Advisory Board and
